Literature DB >> 18373647

Roles of organic anion transporters in the renal excretion of perfluorooctanoic acid.

Hatsuki Nakagawa1, Taku Hirata, Tomohiro Terada, Promsuk Jutabha, Daisaku Miura, Kouji H Harada, Kayoko Inoue, Naohiko Anzai, Hitoshi Endou, Ken-Ichi Inui, Yoshikatsu Kanai, Akio Koizumi.   

Abstract

Perfluorooctanoic acid, an environmental contaminant, is found in both wild animals and human beings. There are large species and sex differences in the renal excretion of perfluorooctanoic acid. In the present study, we aimed to characterize organic anion transporters 1-3 (OAT1-3) in human beings and rats to investigate whether the species differences in the elimination kinetics of perfluorooctanoic acid from the kidneys can be attributed to differences in the affinities of these transporters for perfluorooctanoic acid. We used human (h) and rat (r) OAT transient expression cell systems and measured the [(14)C] perfluorooctanoic acid transport activities. Both human and rat OAT1 and OAT3 mediated perfluorooctanoic acid transport to similar degrees. Specifically, the kinetic parameters, K(m), were 48.0 +/- 6.4 microM for h OAT1; 51.0 +/- 12.0 microM for rOAT1; 49.1 +/- 21.4 microM for hOAT3 and 80.2 +/- 17.8 microM for rOAT3, respectively. These data indicate that both human and rat OAT1 and OAT3 have high affinities for perfluorooctanoic acid and that the species differences in its renal elimination are not attributable to affinity differences in these OATs between human beings and rats. In contrast, neither hOAT2 nor rOAT2 transported perfluorooctanoic acid. In conclusion, OAT1 and OAT3 mediated perfluorooctanoic acid transport in vitro, suggesting that these transporters also transport perfluorooctanoic acid through the basolateral membrane of proximal tubular cells in vivo in both human beings and rats. Neither human nor rat OAT2 mediated perfluorooctanoic acid transport. Collectively, the difference between the perfluorooctanoic acid half-lives in human beings and rats is not likely to be attributable to differences in the affinities of these transporters for perfluorooctanoic acid.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18373647     DOI: 10.1111/j.1742-7843.2007.00155.x

Source DB:  PubMed          Journal:  Basic Clin Pharmacol Toxicol        ISSN: 1742-7835            Impact factor:   4.080


  20 in total

1.  Perfluoroalkyl acids, hyperuricemia and gout in adults: Analyses of NHANES 2009-2014.

Authors:  Franco Scinicariello; Melanie C Buser; Lina Balluz; Kimberly Gehle; H Edward Murray; Henry G Abadin; Roberta Attanasio
Journal:  Chemosphere       Date:  2020-06-20       Impact factor: 7.086

2.  Environmental and biological monitoring of persistent fluorinated compounds in Japan and their toxicities.

Authors:  Kouji H Harada; Akio Koizumi
Journal:  Environ Health Prev Med       Date:  2008-11-11       Impact factor: 3.674

3.  Na+/Taurocholate Cotransporting Polypeptide and Apical Sodium-Dependent Bile Acid Transporter Are Involved in the Disposition of Perfluoroalkyl Sulfonates in Humans and Rats.

Authors:  Wen Zhao; Jeremiah D Zitzow; David J Ehresman; Shu-Ching Chang; John L Butenhoff; Jameson Forster; Bruno Hagenbuch
Journal:  Toxicol Sci       Date:  2015-05-21       Impact factor: 4.849

4.  Hepatic and renal Bcrp transporter expression in mice treated with perfluorooctanoic acid.

Authors:  Lobna M Eldasher; Xia Wen; Michael S Little; Kristin M Bircsak; Lindsay L Yacovino; Lauren M Aleksunes
Journal:  Toxicology       Date:  2013-02-19       Impact factor: 4.221

5.  Phospholipid Levels Predict the Tissue Distribution of Poly- and Perfluoroalkyl Substances in a Marine Mammal.

Authors:  Clifton Dassuncao; Heidi Pickard; Marisa Pfohl; Andrea K Tokranov; Miling Li; Bjarni Mikkelsen; Angela Slitt; Elsie M Sunderland
Journal:  Environ Sci Technol Lett       Date:  2019-02-20

6.  Organic Anion Transporting Polypeptides Contribute to the Disposition of Perfluoroalkyl Acids in Humans and Rats.

Authors:  Wen Zhao; Jeremiah D Zitzow; Yi Weaver; David J Ehresman; Shu-Ching Chang; John L Butenhoff; Bruno Hagenbuch
Journal:  Toxicol Sci       Date:  2017-03-01       Impact factor: 4.849

7.  Association of perfluorooctanoic acid (PFOA) and perfluorooctane sulfonate (PFOS) with uric acid among adults with elevated community exposure to PFOA.

Authors:  Kyle Steenland; Sarah Tinker; Anoop Shankar; Alan Ducatman
Journal:  Environ Health Perspect       Date:  2010-02       Impact factor: 9.031

Review 8.  Epidemiologic evidence on the health effects of perfluorooctanoic acid (PFOA).

Authors:  Kyle Steenland; Tony Fletcher; David A Savitz
Journal:  Environ Health Perspect       Date:  2010-04-27       Impact factor: 9.031

9.  Development of PBPK models for PFOA and PFOS for human pregnancy and lactation life stages.

Authors:  Anne E Loccisano; Matthew P Longnecker; Jerry L Campbell; Melvin E Andersen; Harvey J Clewell
Journal:  J Toxicol Environ Health A       Date:  2013

10.  Comparing models for perfluorooctanoic acid pharmacokinetics using Bayesian analysis.

Authors:  John F Wambaugh; Hugh A Barton; R Woodrow Setzer
Journal:  J Pharmacokinet Pharmacodyn       Date:  2009-01-08       Impact factor: 2.745

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.